A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients with Bronchiectasis

Update Il y a 4 ans
Reference: EUCTR2008-000753-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate whether AZD9668 shows evidence of efficacy in bronchiectasis patients by investigation of: · Absolute and percentage neutrophil cell count in the sputum · Signs and symptoms of bronchiectasis (including effects on quality of life)


Inclusion criteria

  • Bronchiectasis